Clinical trial Recruiting at 1 site Observational Ages 18 and up

Psychological distress and its effects on treatment adherence, outcomes, and quality of life in people with cancer

Official title: Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life

Run by First Affiliated Hospital of Wenzhou Medical University · NCT07193329 · Data updated 2026-11-12

This study will try to see if anxiety and depression change how adults with cancer stick to treatment, their health outcomes, and their quality of life over three years.

More Psychological Distress trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorFirst Affiliated Hospital of Wenzhou Medical University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Wenzhou, Zhejiang)
StatusRecruiting
StartedJuly 22, 2025
Main results expectedJuly 1, 2028
Study endsJuly 1, 2028
Registry record updatedSeptember 25, 2025
Trial IDNCT07193329 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with pathologically or radiologically confirmed malignant tumors who are planning to receive or are receiving systemic cancer treatment and who can complete questionnaires and provide informed consent.

Probably not a fit

Patients with severe systemic illnesses, major cognitive impairment preventing questionnaire completion, or those likely to have incomplete data or be lost to follow-up are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, longitudinal study enrolling adults with confirmed malignant tumors who are planning to receive or are receiving systemic cancer treatment. Participants will complete GAD-7 and PHQ-9 questionnaires to measure anxiety and depression, while treatment adherence, clinical outcomes, and quality-of-life measures are recorded during a 3-year follow-up. No experimental interventions are given; the study examines natural variation in psychological distress and links it to adherence and outcomes. Results aim to clarify associations that could inform supportive care and follow-up strategies.

Why it matters

Potential benefit: If successful, the findings could help identify patients who need psychological support to improve treatment adherence and quality of life.

How similar studies have gone: Previous observational research has linked anxiety and depression with poorer adherence, worse clinical outcomes, and lower quality of life in cancer populations, so this study builds on established evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (1) Confirmed malignant tumors by imaging or pathology (such as hepatobiliary carcinoma, gastric cancer, breast cancer, lung cancer, etc.)
* (2) Planning to receive or currently undergoing systemic treatment (such as surgery, chemotherapy, TACE, targeted therapy, etc.)
* (3) Age ≥18 years old
* (4) Sign the informed consent form and voluntarily participate in this study

Exclusion Criteria:

* (1) Combined with severe systemic diseases (such as severe cardiovascular and cerebrovascular diseases)
* (2) There is severe cognitive impairment and it is impossible to complete the questionnaire assessment
* (3) Incomplete clinical data or loss to follow-up

Where it's running

  • First Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.